Apremilast Beats Placebo in Early PsA Affecting Few Joints

by admin on November 15, 2023

Source link : https://www.newshealth.biz/health-news/apremilast-beats-placebo-in-early-psa-affecting-few-joints/

SAN DIEGO – Patients with early oligoarticular psoriatic arthritis (PsA) who took apremilast (Otezla) had more than double the response rate of placebo-treated patients by 16 weeks in a double-blind and randomized phase 4 study. Dr Philip Mease Oligoarticular PsA can significantly affect quality of life even though few joints are affected, and there’s a lack […]

Author : News Health

Publish date : 2023-11-15 16:34:13

Copyright for syndicated content belongs to the linked Source.

Apremilast Beats Placebo in Early PsA Affecting Few Joints- Apremilast Beats Placebo in Early PsA Affecting Few Joints * Apremilast Beats Placebo in Early PsA Affecting Few Joints | Apremilast Beats Placebo in Early PsA Affecting Few Joints | Apremilast Beats Placebo in Early PsA Affecting Few Joints | Apremilast Beats Placebo in Early PsA Affecting Few Joints | Apremilast Beats Placebo in Early PsA Affecting Few Joints | Apremilast Beats Placebo in Early PsA Affecting Few Joints | Apremilast Beats Placebo in Early PsA Affecting Few Joints | Apremilast Beats Placebo in Early PsA Affecting Few Joints | | Apremilast Beats Placebo in Early PsA Affecting Few Joints | | Apremilast Beats Placebo in Early PsA Affecting Few Joints | | Apremilast Beats Placebo in Early PsA Affecting Few Joints |